Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Account Payables (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Change in Account Payables for 5 consecutive years, with -$82000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables fell 135.19% year-over-year to -$82000.0, compared with a TTM value of -$384000.0 through Sep 2025, down 372.34%, and an annual FY2024 reading of $96000.0, up 7.87% over the prior year.
  • Change in Account Payables was -$82000.0 for Q3 2025 at Lucid Diagnostics, down from $4000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.0 million in Q1 2022 and bottomed at -$1.4 million in Q4 2021.
  • Average Change in Account Payables over 5 years is -$74473.7, with a median of -$57000.0 recorded in 2022.
  • The sharpest move saw Change in Account Payables skyrocketed 364.91% in 2023, then crashed 658.33% in 2024.
  • Year by year, Change in Account Payables stood at -$1.4 million in 2021, then soared by 96.06% to -$57000.0 in 2022, then surged by 364.91% to $151000.0 in 2023, then decreased by 29.8% to $106000.0 in 2024, then crashed by 177.36% to -$82000.0 in 2025.
  • Business Quant data shows Change in Account Payables for LUCD at -$82000.0 in Q3 2025, $4000.0 in Q2 2025, and -$412000.0 in Q1 2025.